Status | Study |
Recruiting |
Study Name: Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours Condition: Bile Duct Cancer Date: 2015-10-26 Interventions: Drug: GEMCIS |
Recruiting |
Study Name: Study of LOXO-101 (Larotrectinib) in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE) Condition: Carcinoma, Non-Small-Cell Lung Thyroid Neoplasms Sarcoma Date: 2015-10-12 Interventions: Drug: LOXO-101 Oral capsule of LOXO-101 - 100mg BID |
Enrolling by invitation |
Study Name: Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy Condition: Periampullary Tumor Common Bile Duct Neoplasms Date: 2015-10-07 Interventions: Drug: Preoperative hyperbaric oxygen Subjects undergoing preoperative HBOT will be treated with up to 2. |
Withdrawn |
Study Name: Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery Condition: Gastric Cancer Pancreatic Cancer Bile Duct Cancer Date: 2015-04-27 Interventions: Drug: The marketed product 2-5 MBq/kg 18F-fluorodeoxyglucose |
Recruiting |
Study Name: Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder Condition: Carcinoma of Intrahepatic and Extra-hepatic Biliary System Carcinoma of Gallbladder Date: 2015-02-18 Interventions: Drug: DKN-01 Administration by |
Active, not recruiting |
Study Name: Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers Condition: Liver Cancer Anxiety Disorder Depression Date: 2015-01-23 Interventions: Other: Early palliative care |
Recruiting |
Study Name: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer Condition: Breast Cancer Colon Cancer Extrahepatic Bile Duct Cancer Date: 2014-10-09 Interventions: Procedure: radionuclide imaging |
Recruiting |
Study Name: Single Agent Regorafenib in Refractory Advanced Biliary Cancers Condition: Cancer of the Bile Duct Date: 2014-04-11 Interventions: Drug: Regorafenib Four 40 mg regorafenib tables should be taken in the morning with approximately 8 flui |
Active, not recruiting |
Study Name: PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer Condition: Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Date: 2014-03-13 Interventions: Procedure: PET scan Undergo PE |
Terminated |
Study Name: Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) Condition: Hilar Cholangiocarcinoma Date: 2014-03-06 Interventions: Drug: Photodynamic therapy-Photofrin |